Transcription of Appendix A: Schedule and Recommendations: Recommended …
{{id}} {{{paragraph}}}
Appendix AAAppendix A-20 Recommended and minimum ages and intervals between vaccine doses(a),(b),(c),(d)Vaccine and dose numberRecommended age for this doseMinimum age for this doseRecommended interval to next doseMinimum interval to next doseDTaP-1(e)2 months6 weeks8 weeks4 weeksDTaP-24 months10 weeks8 weeks4 weeksDTaP-36 months14 weeks 6-12 months(f )6 months(f )DTaP-415-18 months15 months(f )3 years6 monthsDTaP-5(g)4-6 years4 years HepA-1(e)12-23 months12 months6-18 months6 monthsHepA-2 18 months18 months HepB-1(h)BirthBirth4 weeks-4 months4 weeksHepB-21-2 months4 weeks8 weeks-17 months8 weeksHepB-3(i)6-18 months24 weeks Hib-1(j)2 months6 weeks8 weeks4 weeksHib-24 months10 weeks8 weeks4 weeksHib-3(k)6 months14 weeks6-9 months8 weeksHib-412-15 months12 months HPV-1 (Two-Dose Series)(l)11-12 years9 years6 months5 monthsHPV-211-12 years (+6 months)9 years +5 months(m) HPV-1(n) (Three-Dose Series)11-12 years9 years1-2 months4 weeksHPV-211-12 years (+1-2 months)9 years (+4 weeks)4 months12 weeks (n)HPV-3(n)11-12 years (+6 months)9 years
tetanus and diphtheria toxoids; Tdap = tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis. (a) Combination vaccines are available. Use of licensed combination vaccines is generally preferred to separate injections of their equivalent component vaccines. When
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}